226 related articles for article (PubMed ID: 26376467)
1. Expression of proinflammatory cytokine interleukin-6 in tissue samples of human prostate obtained by needle biopsy.
Miličević N; Mrčela M; Galić J; Marjanović K
Pathol Res Pract; 2015 Nov; 211(11):865-70. PubMed ID: 26376467
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical localization of interleukin-6 and its receptor in benign, premalignant and malignant prostate tissue.
Hobisch A; Rogatsch H; Hittmair A; Fuchs D; Bartsch G; Klocker H; Bartsch G; Culig Z
J Pathol; 2000 Jul; 191(3):239-44. PubMed ID: 10878544
[TBL] [Abstract][Full Text] [Related]
3. The diagnostic utility of novel immunohistochemical marker ERG in the workup of prostate biopsies with "atypical glands suspicious for cancer".
He H; Magi-Galluzzi C; Li J; Carver P; Falzarano S; Smith K; Rubin MA; Zhou M
Am J Surg Pathol; 2011 Apr; 35(4):608-14. PubMed ID: 21383613
[TBL] [Abstract][Full Text] [Related]
4. [The morphogenesis of cancer of the prostate (immunohistochemical research)].
Vorobĭova LR
Lik Sprava; 1998 May; (3):87-90. PubMed ID: 9695575
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical expression of interleukin-2 receptor and interleukin-6 in patients with prostate cancer and benign prostatic hyperplasia: association with asymptomatic inflammatory prostatitis NIH category IV.
Engelhardt PF; Seklehner S; Brustmann H; Lusuardi L; Riedl CR
Scand J Urol; 2015 Apr; 49(2):120-6. PubMed ID: 25363611
[TBL] [Abstract][Full Text] [Related]
6. IL-6, IL-10 and HSP-90 expression in tissue microarrays from human prostate cancer assessed by computer-assisted image analysis.
Cardillo MR; Ippoliti F
Anticancer Res; 2006; 26(5A):3409-16. PubMed ID: 17094460
[TBL] [Abstract][Full Text] [Related]
7. Expression of the VEGF-receptor Flt-1 in benign, premalignant and malignant prostate tissues.
Hahn D; Simak R; Steiner GE; Handisurya A; Susani M; Marberger M
J Urol; 2000 Aug; 164(2):506-10. PubMed ID: 10893635
[TBL] [Abstract][Full Text] [Related]
8. STEAP1 is overexpressed in prostate cancer and prostatic intraepithelial neoplasia lesions, and it is positively associated with Gleason score.
Gomes IM; Arinto P; Lopes C; Santos CR; Maia CJ
Urol Oncol; 2014 Jan; 32(1):53.e23-9. PubMed ID: 24239460
[TBL] [Abstract][Full Text] [Related]
9. Transforming growth factor beta 1 and androgen receptors in prostate neoplasia.
Cardillo MR; Petrangeli E; Salvatori L; Ravenna L; Di Silverio F
Anal Quant Cytol Histol; 2000 Oct; 22(5):403-10. PubMed ID: 11064817
[TBL] [Abstract][Full Text] [Related]
10. Apoptosis incidence and protein expression of p53, TGF-beta receptor II, p27Kip1, and Smad4 in benign, premalignant, and malignant human prostate.
Zeng L; Rowland RG; Lele SM; Kyprianou N
Hum Pathol; 2004 Mar; 35(3):290-7. PubMed ID: 15017584
[TBL] [Abstract][Full Text] [Related]
11. Expression of prostate specific membrane antigen (PSMA) in prostatic adenocarcinoma and prostatic intraepithelial neoplasia.
Marchal C; Redondo M; Padilla M; Caballero J; Rodrigo I; García J; Quian J; Boswick DG
Histol Histopathol; 2004 Jul; 19(3):715-8. PubMed ID: 15168332
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical expression of retinoblastoma and p53 tumor suppressor genes in prostatic intraepithelial neoplasia: comparison with prostatic adenocarcinoma and benign prostate.
Tamboli P; Amin MB; Xu HJ; Linden MD
Mod Pathol; 1998 Mar; 11(3):247-52. PubMed ID: 9521470
[TBL] [Abstract][Full Text] [Related]
13. The relation of beclin 1 and bcl-2 expressions in high grade prostatic intraepithelial neoplasia and prostate adenocarcinoma: a tissue microarray study.
Baspinar S; Bircan S; Orhan H; Kapucuoglu N; Bozkurt KK
Pathol Res Pract; 2014 Jul; 210(7):412-8. PubMed ID: 24690321
[TBL] [Abstract][Full Text] [Related]
14. Transforming growth factor-beta expression in prostate neoplasia.
Cardillo MR; Petrangeli E; Perracchio L; Salvatori L; Ravenna L; Di Silverio F
Anal Quant Cytol Histol; 2000 Feb; 22(1):1-10. PubMed ID: 10696454
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical study of the expression of epidermal growth factor receptor in benign prostatic hypertrophy, prostatic intraepithelial neoplasia and prostatic carcinoma.
Rana S; Sen R; Kalra R; Arora B; Sharma P; Gahlawat S
Indian J Pathol Microbiol; 2006 Oct; 49(4):495-9. PubMed ID: 17183836
[TBL] [Abstract][Full Text] [Related]
16. [Detection of telomerase activity in prostate needle-biopsy samples].
Wang X; Zhang Y; Ding Q; Ye L; Zhai L; Jia W
Zhonghua Wai Ke Za Zhi; 1999 Dec; 37(12):762-4. PubMed ID: 11829949
[TBL] [Abstract][Full Text] [Related]
17. p63 protein expression is rare in prostate adenocarcinoma: implications for cancer diagnosis and carcinogenesis.
Parsons JK; Gage WR; Nelson WG; De Marzo AM
Urology; 2001 Oct; 58(4):619-24. PubMed ID: 11597556
[TBL] [Abstract][Full Text] [Related]
18. Histopathologic characterisation of prostate diseases in Port Harcourt.
Obiorah CC; Nwosu SO
Niger Postgrad Med J; 2009 Jun; 16(2):158-61. PubMed ID: 19606198
[TBL] [Abstract][Full Text] [Related]
19. The utility of ERG/P63 double immunohistochemical staining in the diagnosis of limited cancer in prostate needle biopsies.
Yaskiv O; Zhang X; Simmerman K; Daly T; He H; Falzarano S; Chen L; Magi-Galluzzi C; Zhou M
Am J Surg Pathol; 2011 Jul; 35(7):1062-8. PubMed ID: 21623182
[TBL] [Abstract][Full Text] [Related]
20. Microvessel density as a molecular marker for identifying high-grade prostatic intraepithelial neoplasia precursors to prostate cancer.
Sinha AA; Quast BJ; Reddy PK; Lall V; Wilson MJ; Qian J; Bostwick DG
Exp Mol Pathol; 2004 Oct; 77(2):153-9. PubMed ID: 15351240
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
